Correlative evidence suggests that GABAergic signaling plays an important role in the regulation of activity-dependent hippocampal neurogenesis and emotional behavior in adult mice. However, whether these are causally linked at the molecular level remains elusive. Nuclear factor of activated T cell (NFAT) proteins are activity-dependent transcription factors that respond to environmental stimuli in different cell types, including hippocampal newborn neurons. Here, we identify NFATc4 as a key activity-dependent transcriptional regulator of GABA signaling in hippocampal progenitor cells via an unbiased high-throughput genome-wide study. Next, we demonstrate that GABA A receptor (GABA A R) signaling modulates hippocampal neurogenesis through NFATc4 activity, which in turn regulates GABRA2 and GABRA4 subunit expression via binding to specific promoter responsive elements, as assessed by ChIP and luciferase assays. Furthermore, we show that selective pharmacological enhancement of GABA A R activity promotes hippocampal neurogenesis via the calcineurin/NFATc4 axis. Importantly, the NFATc4-dependent increase in hippocampal neurogenesis after GABA A R stimulation is required for the suppression of the anxiety response in mice. Together, these data provide a novel molecular insight into the regulation of the anxiety response in mice, suggesting that the GABA A R/NFATc4 axis is a druggable target for the therapy of emotional disorders.
Introduction
Functional and neuroimaging studies have correlated hippocampal activity, integrity, and size with emotional behavior in both humans and animals (Gilbertson et al., 2002; Campbell et al., 2004; Kitayama et al., 2005; Irle et al., 2010; Kheirbek et al., 2013) . Specifically, it has been shown that impaired adult hippocampal neurogenesis is implicated in the pathogenesis of a number of cognitive and psychiatric disorders (Snyder et al., 2011; Kheirbek et al., 2012; Petrik et al., 2012; Sahay et al., 2011) and that the effective treatment of anxiety/depression-related behavior in rodents requires intact hippocampal neurogenesis (Santarelli et al., 2003; David et al., 2009; Surget et al., 2011) . Importantly, the finding that adult neurogenesis occurs in the adult human hippocampus (Spalding et al., 2013) at rates comparable to those described in mice (Kempermann et al., 1997) suggests that it might as well have a functional role in the regulation of cognitive and emotional human behavior (Kheirbek and Hen, 2013) . Therefore, the elucidation of the molecular link between adult hippocampal neurogenesis and emotional responses in mice might be critical for the development of more effective treatments for clinical anxiety disorders. GABA signaling, which is one of the most important regulator of activity-dependent hippocampal neurogenesis during adulthood , is known to play a central role in the pathophysiology of anxiety disorders (Lydiard, 2003; Nemeroff, 2003) . However, it is not clear whether GABAergic modulation of adult neurogenesis affects anxiety levels in mice and which molecular players causally regulate these two events. It has been shown that GABAergic excitation shapes neural maturation and differentiation specifically by the enhancement of GABA A receptor (GABA A R) expression and activity in neural progenitor cells (Tozuka et al., 2005; Ge et al., 2006) . GABA A Rs are hetero-oligomeric complexes composed of five subunits that are expressed and assembled in a cell type-and spatiotemporal-specific fashion in the brain. The composition of the GABA A R subunits determines their functional and pharmacological properties. Specifically, the functional expression of the ␣2 (GABRA2) and ␣4 (GABRA4) GABA A R subunits in neural progenitor cells controls adult neurogenesis in the mouse DG (Duveau et al., 2011) . Vertebrate GABA A R subunits are organized in several gene clusters localized on different chromosomes originated by gene duplication. Interestingly, GABRA2 and GABRA4 subunits belong to the same genomic cluster, and this genomic organization might have been conserved to facilitate transcriptional coregulation (Joyce, 2007) . However the transcriptional machinery involved in the coordinate regulation of GABA A R subunits in hippocampal neural progenitor cells still needs to be investigated.
Here, we demonstrate with several lines of evidence that GABA A R signaling operates through NFATc4 activity, an activity-dependent transcription factor expressed in hippocampal adult-born neurons (Quadrato et al., 2012) . NFATc4 modulates hippocampal neurogenesis by direct transcriptional coregulation of GABRA2 and GABRA4 subunit expression by binding to specific responsive elements on their promoters. Furthermore, we show that selective pharmacological enhancement of GABA A R activity promotes hippocampal neuronal differentiation via calcineurin/NFATc4, which in turn modulates innate anxiety levels in adult mice. These findings provide a causal link between modulation of hippocampal neurogenesis and changes in anxiety levels by proposing NFATc4 as a key transcriptional regulator in GABAergic signaling and suggest that NFATc4/ GABAergic signaling is a druggable target for the therapy of emotional disorders.
Materials and Methods
Animals. Wild-type (WT) and nuclear factor of activated T cell-knockout (NFATc4 Ϫ/Ϫ ) mice (Wilkins et al., 2002) were housed under standard conditions with food and water available ad libitum and kept on a 12 h dark/light cycle. Mice were maintained on a mixed C57BL/6 and 129S7 genetic background. Adult littermate male mice (between 2 and 5 months of age) were used in the study. All experiments were performed according to National Institutes of Health and European Union Animal Care standards and local animal care guidelines at the University of Tübingen.
Cell culture of adult hippocampal neurospheres and pharmacological treatment. For in vitro experiments, we used adult hippocampal neural stem cell cultures isolated after selective microdissection of the DG of 3-to 4-month-old WT, NFATc4
Ϫ/Ϫ and Hes5-GFP mice (kindly provided by Dr. Verdon Taylor). Cultures were maintained following the same procedures described previously (Quadrato et al., 2012) . All neurospheres were cultured in serum-free DMEM/F-12 medium (1:1; Invitrogen) containing the following: 200 mM L-glutamine (Invitrogen), 100 U penicillin/streptomycin (Invitrogen), 2% B27 supplement without vitamin A (Invitrogen), 20 ng/ml epidermal growth factor (Millipore), 20 ng/ml basic fibroblast growth factor (bFGF; Millipore), and 2.5 g/ml heparin (Sigma-Aldrich). For neuronal differentiation, neural progenitor cells were transferred to differentiation medium [DMEM/F-12 medium containing the following: 100 U penicillin/streptomycin, 200 mM L-glutamine, 2% B27 supplement with vitamin A (Life Technologies), 0.1 M retinoic acid (Sigma-Aldrich), and 0.5 M forskolin (Calbiochem)] with 20 ng/ml bFGF overnight, and then switched to differentiation medium without bFGF for up to 5 d. In differentiating conditions, the following drugs were administrated in culture medium: 100 ng/ml cyclosporin A (CsA; LC Laboratories), 100 ng/ml BDNF (R&D Systems), or 10 M muscimol (Sigma-Aldrich). WT and NFATc4 Ϫ/Ϫ neurospheres (NSPs) were infected with control-dsred and NFATc4-dsred expressing retroviral constructs and seeded at a density of 1 ϫ 10 5 cells into 24-well tissue culture plates in differentiation medium. Muscimol was added to the medium and cells were incubated for 1, 2 or 5 d.
Immunocytochemistry. Immunocytochemistry was performed as described previously (Quadrato et al., 2012) . Primary antibodies used were as follows: monoclonal rabbit anti-NFATc4 (1:100; Cell Signaling Technology), polyclonal rabbit anti-GABAR ␣ 4 (1:200; Abcam), polyclonal goat anti-GABAR ␣ 4 (1:100; Santa Cruz Biotechnology), polyclonal rabbit anti-GABAR ␣ 2 (1:200; Alomone labs), polyclonal goat anti-GABAR ␣ 2 (1:100; Santa Cruz Biotechnology), monoclonal mouse antinestin (1:200; Millipore), monoclonal anti-MAP2 (1:200; Abcam), polyclonal rabbit anti-cleaved caspase-3 (1:500; Cell Signaling Technology), monoclonal mouse anti-SOX2 (1:100; Abcam), polyclonal rabbit anti-SOX2 (1:400; Abcam), monoclonal mouse anti-SOX2 (1:400; Abcam), and polyclonal chicken anti-GFP (1:500; Abcam). The secondary antibodies used were as follows: Alexa Fluor goat anti-mouse 488, goat anti-rabbit 546, goat anti-rat 647, donkey anti-goat 488, donkey antirabbit 568, and donkey anti-mouse 647 (1:1500; Invitrogen). Cell nuclei were stained with Hoechst staining (1:5000; Invitrogen) and the glass coverslips were mounted using DAKO fluorescence mounting medium. Cells were imaged using an Axiovert 200M (Zeiss) microscope with AxioVision software (version 4.8.1; Zeiss) .
Fluorescence intensity threshold analysis. Quantification of the number of viable cells with a staining intensity for anti-GABRA2 or anti-GABRA4 antibodies above the "intermode" threshold was made using ImageJ software. Approximately 100 cells were counted for each coverslip. Cells above intensity threshold were divided by the total number of viable cells to calculate their percentage. Viability of cells was determined using DAPI staining.
Microarray analysis. Hippocampal NSP cultures derived from WT and NFATc4 Ϫ/Ϫ mice were differentiated for 1 d with BDNF added to the medium. Total RNA was isolated from the cells using PureLink RNA micro kit (Invitrogen) according to manufacturer's instructions. Whole transcriptome analysis was performed using an Affymetrix Mouse Gene 1.1 ST array on the Affymetrix GeneTitan System. For this purpose, triplicates of each sample were analyzed.
RNA quality was evaluated on Agilent 2100 Bioanalyzer with RNA integrity numbers (RINs) ranging from 8 to 10; all RINs Ͼ8 were considered optimal for downstream applications. Double-stranded cDNA was synthesized from 100 ng of total RNA and subsequently linearly amplified and biotinylated using the GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) according to the manufacturer's instructions. Fifteen micrograms of labeled and fragmented cDNA was hybridized to GeneChip Mouse Gene 1.1 ST arrays (Affymetrix). After hybridization, the arrays were washed and stained in a Fluidics Station 450 (Affymetrix) with the recommended washing procedure. Biotinylated cDNA bound to target molecules was detected with streptavidin-coupled phycoerythrin, biotinylated anti-streptavidin IgG antibodies and again streptavidin-coupled phycoerythrin according to the protocol. Arrays were scanned using the Affymetrix GeneTitan scanner and AGCC 3.0 software. Scanned images were subjected to visual inspection to check for hybridization artifacts and proper grid alignment and analyzed with Expression Console 1.0 (Affymetrix) to generate report files for quality control. Normalization of raw data was performed with Partek software, applying a robust multichip average algorithm. Hierachical cluster analysis was performed with average linkage for genes. Heat maps were generated with Bioconductor package gplots. Gene ontology classification and pathway analyses was performed using Ingenuity Pathway Analysis software (http://www.ingenuity.com/).
Quantitative PCR. Cells were differentiated and total RNA was extracted using PureLink RNA micro kit according to the manufacturer's protocol, followed by cDNA synthesis from 1 g of RNA using oligodT (SuperScript II Reverse Transcriptase; Invitrogen). Quantitative PCR (qPCR) was performed using 7500 Fast Real-Time PCR System software version 2.0.4 (Applied Biosystems). The reaction mix was composed of SYBR Green Mix (1:2; Invitrogen), 100 nM primers (GABRA4 forward: ACGAGAAATTGTGCCCGGAA, GABRA4 reverse: ACATCAGAAA CGGGCCCAAA, GABRA2 forward: GCTCGAAATTCCCTCCCGAA, GABRA2 reverse: ACTACACTCTTCCCGTCCCA, GABBR1 forward: CAGTCGCTGTGTCCGAATCT, GABBR1 reverse: GTCGGGGTCA CATCGGAAAT, GABRB1 forward: CGCCGACTAAGTTGCATTCC, GABRB1 reverse: ACCATAGCAACCATCACGGG, GABBR2 forward: GTGAATCAGGGGCATTCTGCT, GABBR2 reverse: AGCCTCCTGA TGGACCACTT) and 1 l of template (1:5 dilution of reverse transcription sample) in a total volume of 20 l. All reactions were conducted in the same conditions (50°C, 20 s; 95°C, 15 min for 1 cycle; 95°C, 15 s; 60°C, 30 s; 72°C, 1 min for 40 cycles.). After that, the melting curve analysis was applied (95°C, 15 s, 60°C, 1 min, 95°C. 30 s, 60°C, 15 s). Samples were run in technical and biological triplicates and normalized to endogenous GAPDH expression levels. ⌬⌬CT analysis method was applied for the fold change calculations of the mRNA expression levels.
ChIP assay. The ChIP assay was performed as described by Floriddia et al. (2011) . Briefly, 1.5 ϫ 10 5 neural progenitor cells were differentiated for 1 d in the following conditions: WT BDNF-treated, NFATc4 Ϫ/Ϫ BDNF-treated, WT CsA-treated, and NFATc4 Ϫ/Ϫ CSA-treated. Cells were fixed using formaldehyde solution at a final concentration of 1% for 30 min at 37°C. After cell lysis (0.5% SDS, 100 mM NaCl, 50 mM Tris HCl, pH 8.0, 5 mM EDTA), extracts were sonicated to shear DNA into 200 -1000 bp lengths. Sheared chromatin solutions were incubated overnight at 4°C with rabbit monoclonal anti-NFATc4 antibody (Cell Signaling Technology) and normal rabbit IgG antibody (Cell Signaling Technology) with rotation. After incubation, the samples were immunoprecipitated with ChIP Grade Protein G Magnetic Beads (Cell Signaling Technology) and incubated for 2 h at 4°C with rotation. The precipitated complexes were washed repeatedly and incubated for 30 min at 65°C in parallel with input samples to elute the chromatin from the beads. Later, the beads were removed and samples were incubated 2 h at 65°C to reverse the crosslinks. DNA was isolated by phenol/chloroform extraction followed later by ethanol precipitation with sodium acetate. qPCR amplification of isolated DNA samples was performed as described previously using the following primers: GABRA4 forward: AGTTTGTCACTGTCACTTTGGT, GABRA4 reverse: TCCTTTCCCTTAGAAAGCATCAGA, GABRA2 forward: ACCATAGGTCAGGCTCTCCA, GABRA2 reverse: TCCTGACAT TGTCCAGTCTCC, GABRA2.1 forward: ACCACAGGTGTCCAACAT CAA, GABRA2.1 reverse: ATTTGAGAGGCTTCGTCAGCA. For ChIP primer design, potential NFAT-binding sites within the predicted gabra2 and gabra4 promoter regions were identified using MatInspector algorithm in Genomatix software (http://www.genomatix.de/). Each immunoprecipitation sample was normalized to input and IgG immunoprecipitation fractions for fold enrichment calculations using Ct values.
Dual luciferase reporter assay. Hippocampal progenitor cells derived from WT and NFATc4 Ϫ/Ϫ animals were seeded at a density of 1 ϫ 10 4 cells in 96-well plates under the conditions of WT BDNF-treated, WT vehicle-treated, NFATc4 Ϫ/Ϫ BDNF-treated, NFATc4 Ϫ/Ϫ vehicle-treated, and WT CsA-treated. Cells were cotransfected with one of the LightSwitch GoClone reporter plasmids in which the luciferase expression is dependent on gabra4 or gabra2 promoter (SwitchGear Genomics) and with the Cypridina TK control construct using FuGENE HD transfection reagent. Reporter assays were performed at 24 h after transfection with LightSwitch Dual Assay system (SwitchGear Genomics) and plates were read using a luminescence plate reader (Mithras LB940 96-well plate reader; Berthold Technologies). All transfections were conducted in triplicate.
Viral vectors and stereotaxic injection. For NFATc4 overexpression, full-length human NFATc4 cDNA (Addgene) was subcloned into a retrovial backbone containing a CAG promoter followed by internal ribosome entry site (IRES)-dsredExpress2. As a control, a CAG-IRESdsredExpress2 vector was used. For stereotaxic injections, anesthetized (90 mg/kg ketamine and 10 mg/kg xylazine) mice were mounted on a stereotaxic alignment system (Steolting). Mice were injected unilaterally at two sites of the DG with 0.75 l of retroviral suspension (1:5 dilution in PBS) as described previously (Gu et al., 2011) . Coordinates from bregma of the first site were as follows: Ϫ2 mm anteroposterior, Ϯ1.6 mm lateral, 2.5 mm ventral, and for the second site, Ϫ3 mm anterioposterior, Ϯ2.6 mm lateral, 3.2 mm ventral. Animals were returned to the standard housing conditions until the desired time points after injection.
Drug treatment and BrdU labeling. Mice were injected intraperitoneally once every 24 h with muscimol (M1523; Sigma-Aldrich) at 4 mg/kg body weight in 0.05 M HCl for 24 d. For the first 3 d of treatment, animals were also injected every 12 h with BrdU (B5002; Sigma-Aldrich) at 75 mg/kg body weight in saline. For suppression of neurogenesis, temozolomide (T2577; Sigma-Aldrich) was injected at 25 mg/kg body weight in DMSO on the first 3 d of a week for 4 weeks, as described previously (Garthe et al., 2009) . For the control group, DMSO was injected following the same paradigm.
Tissue preparation and immunohistochemistry. Mice were perfused transcardially with 0.1 M PBS solution, pH 7.4, followed by 4% PFA, pH 7.4. Brains were dissected and postfixed overnight at 4°C and were then immersed in 30% sucrose for cryoprotection. Free-floating 40 m coronal sections spanning the whole hippocampus were cut using a Leica cryostat, collected in cryoprotectant solution, and stored at Ϫ20°C until further use. Primary antibodies used were rat monoclonal antibody antiBrdU (1:100; Novus Biologicals), mouse monoclonal anti-BrdU (1:400, Cell Signaling Technology), rabbit polyclonal anti-calbindin (anti-CB, 1:3000; Swant), mouse monoclonal anti-RFP (1:600; Abcam), rat monoclonal anti-GFAP (1:400; Invitrogen), mouse monoclonal anti-nestin (1:100; Millipore), goat polyclonal anti-doublecortin (1:200; Santa Cruz Biotechnology). The secondary antibodies used were as follows: Alexa Fluor goat anti-mouse 488, goat anti-rabbit 568, goat anti-rat 488, donkey anti-rabbit 568, donkey anti-mouse 488, goat anti-rabbit 647, and goat anti-rat 568 (Invitrogen), biotinylated anti-mouse (1:200; Vector Laboratories), and streptavidin 488 (1:400; Invitrogen).
For BrdU detection, DNA was denatured by exposing sections to 2 N HCl for 35 min at 37°C, followed by two washes in 0.1 M sodium tetraborate buffer, pH 8.5, for 10 min at room temperature. For NFATc4 detection, antigen retrieval [10 mM citric acid (Roth), 2 mM EDTA (Sigma-Aldrich), and 0.05% Tween 20 (Roth), pH 6.2] was performed.
Cell counting and stereology. For quantification of the percentage of RFP and CB double-positive cells in adult-born neurons, the percentage of RFP ϩ /CB ϩ cells over the total number of RFP ϩ cells was assessed in the DG of all the groups. The total number of BrdU ϩ cells, the total number of BrdU ϩ /CB ϩ cells, and the total number of BrdU ϩ /GFAP ϩ cells were assessed in WT and NFATc4 Ϫ/Ϫ mice treated with either muscimol or vehicle. The number of positive cells was determined in every tenth section in a series of 40 m coronal sections spanning the complete DG using the optical dissector principle. Fluorescent signals were detected using confocal laser microscopy (LSM 510 Axiovert 200M; Zeiss). Positive cells were counted using a 63ϫ oil objective and cells located in the upper most focal plane were not counted.
Elevated plus maze. To test anxiety-related behavior, WT and NFATc4
Ϫ/Ϫ mice between 2 and 5 months of age were tested using the elevated plus maze (EPM). Mice were placed for 5 minutes on an elevated maze composed of four arms, two with black high walls and two without walls. Each arm was 76.5 cm long and 74 cm elevated above the ground. Mice were placed in the testing room 1 h before test under dim light to allow them to habituate. The sessions were videotaped and the total distance and the distance traveled in closed and open arms were recorded using the Ethovision video-tracking system (Noldus).
Statistical analysis. All numerical analyses were performed using Excel software (Microsoft). To compare the averages between two groups for in vitro, in vivo, and ex vivo experiments, unpaired two-tailed Student's t test was used. For the EPM test, latencies were analyzed using one-way ANOVA (with genotype as independent factor and time spent in open arm as repeated-measure factor) followed by Bonferroni's post hoc test for group comparison. Differences were considered significant at p Ͻ 0.05.
Results

Identification of GABAergic signaling as a target of NFATc4 in adult hippocampal progenitor cells via genome-wide transcriptome analysis
After a search for activity-dependent molecular pathways in adult mouse hippocampal neural precursor cells, we identified GABAergic signaling as a central pathway targeted by NFATc4. This was achieved by carrying out an unbiased high throughput genome wide transcriptome analysis in WT versus NFATc4 Ϫ/Ϫ differentiating neural precursor cells (NPCs) derived from the adult DG. The significance of gene expression changes was calculated using a t test without multiple testing corrections (Partek), selecting all transcripts with a minimum of 1.5-fold change in the expression level and p Ͻ 0.05 (the entire dataset is available upon request). Signal intensities were scaled and centered and the distance between two expression profiles was calculated using the Euclidean distance measure, which clearly shows changes between WT and NFATc4
Ϫ/Ϫ gene expression profiles (Fig. 1A) . Indeed, gene ontology classification and pathway analyses showed that up to 20% of all the dysregulated pathways are neuronal activity dependent (Fig. 1B) . Interestingly, as opposed to other pathways, all of the differentially regulated genes belonging to the GABAR signaling show downregulation in the absence of NFATc4 expression (Fig. 1C) , suggesting NFATc4 as a transcriptional node in the control of GABA signaling. Interestingly, among the members of the GABAergic signaling that were downregulated in NFATc4 Ϫ/Ϫ cells, the subunits of the GABA A R ␣2 (GABRA2), ␣4 (GABRA4), and beta1 (GABRAB1) localize in the same genomic cluster on chromosome 5 ( Fig. 2A) , suggesting direct transcriptional coregulation of these subunits by NFATc4.
Next, we validated gene expression changes of the GABRA2, GABRA4, and GABRAB1 subunits by qRT-PCR. We found that only the GABRA2 and GABRA4 transcripts showed Ͼ2-fold downregulation (fold change Ϯ SEM: GABRA2: 2.0 Ϯ 0.043; GABRB1: Ϫ1.5 Ϯ 0.2; GABRA4: 5.4 Ϯ 0.17; Fig. 2B ) in the absence of NFATc4, so these two subunits became the focus of further experiments.
NFATc4 regulates GABAergic signaling in hippocampal progenitor cells via functional binding to GABRA2 and GABRA4 promoters
To determine whether GABRA subunits are direct transcriptional targets of NFATc4, we analyzed GABRA2 and GABRA4 promoter regions for NFAT consensus binding sites using the MatInspector algorithm of Genomatix software. We found two consensus sites in the promoter region of GABRA2 and one in the promoter region of GABRA4 localized, respectively, 863, 536, and 295 bp upstream of the transcription start site (Fig. 2C,D) . To validate the in silico analysis, we performed a ChIP assay on WT Ϫ/Ϫ NPCs differentiated for 20 h in the presence of BDNF (100 ng/ml). Data are normalized to GAPDH expression and are represented as the fold change of WT over NFATc4 Ϫ/Ϫ . Data are shown as mean Ϯ SEM; n ϭ 3. C, D, Diagrams show putative binding sites (MatInspector) for NFATc4 on the promoter region of the GABRA2 (C) and GABRA4 (D) genes. E-G, ChIP assays indicating that NFATc4 occupies two NFAT-responsive elements on the GABRA2 and one on the GABRA4 promoter, showing enrichment of NFATc4 immunoprecipitation compared with IgG control in WT but not in NFATc4 Ϫ/Ϫ NPCs (fold change). CsA blocks NFATc4 occupancy on both GABRA2 and GABRA4 promoters; one-way ANOVA followed by Bonferroni post hoc test: *p Ͻ 0.01; n ϭ 3. H, I, Dual luciferase reporter assay. Luciferase activity was calculated as the ratio of Renilla/Cypridine luciferase signal in WT and NFATc4 Ϫ/Ϫ NPCs cultured in presence of BDNF (100 ng/ml) for 6 h. RLU, Relative luminescence unit. Data are shown as mean Ϯ SEM; n ϭ 3. *p Ͻ 0.05; **p Ͻ 0.01, StudentЈs t test. J, K, qRT-PCR analysis for GABRA2 (J ) or GABRA4 (K ) genes in WT NPCs infected with dsred retrovirus (WT-dsred) and treated with CSA (100 ng/ml), NFATc4 Ϫ/Ϫ cells infected with dsred retrovirus (NFATc4 Ϫ/Ϫ -dsred), or NFATc4-dsred retrovirus (NFATc4 Ϫ/Ϫ -NFATc4-dsred) and treated with vehicle. Data are expressed as the fold change over WT dsred gene expression levels. Data are shown as mean Ϯ SEM; n ϭ 3; one-way ANOVA followed by Bonferroni post hoc test: *p Ͻ 0.05.
and NFATc4
Ϫ/Ϫ differentiated NPCs. As expected, BDNF treatment (100 ng/ml), which promotes NFATc4 transcriptional activity in NPCs (Quadrato et al., 2012) , drove NFATc4 occupancy of the predicted binding sites on the GABRA2 and GABRA4 promoters. Specifically, we found NFATc4 enrichment over IgG control for all binding sites tested (fold change Ϯ SEM: GABRA2*; WT BDNF, 6.6 Ϯ 0.5; NFATc4 Ϫ/Ϫ BDNF Ϫ1.1 Ϯ Ϫ0.1; GABRA2**; WT BDNF, 4.9 Ϯ 0.6; NFATc4 Ϫ/Ϫ BDNF Ϫ1.4 Ϯ Ϫ0.2; GABRA4; WT BDNF, 9.6 Ϯ 1.1; NFATc4 Ϫ/Ϫ BDNF Ϫ1.0 Ϯ Ϫ0.04; Fig. 2E-G) . Importantly, treatment with CsA, a specific inhibitor of calcineurin/NFAT activity, fully counteracted NFATc4 binding on the GABRA2 and GABRA4 promoters (fold change Ϯ SEM: GABRA2*; WT CsA, Ϫ0.5 Ϯ 0.21; NFATc4 Ϫ/Ϫ CsA, Ϫ0.7 Ϯ 0.5; GABRA2**; WT CsA, Ϫ1.6 Ϯ 0.25; NFATc4 Ϫ/Ϫ CsA, 1.8 Ϯ 0.3; GABRA4; WT CsA, Ϫ1.2 Ϯ 0.25; NFATc4 Ϫ/Ϫ CsA, Ϫ0.7 Ϯ 0.5; Fig. 2E-G) . As expected, there was no enrichment in binding over the IgG control in NFATc4 Ϫ/Ϫ NPCs after both BDNF and CsA treatments ( Fig.  2E-G ). To functionally demonstrate NFATc4 transcriptional activity on GABRA2 and GABRA4 promoters, we cotransfected BDNF-treated WT and NFATc4 Ϫ/Ϫ NPCs with an artificial luciferase reporter construct driven by either GABRA2 or GABRA4 promoters and a constitutively active reporter control construct driven by the HSV-TK promoter. We observed that BDNF activated both the GABRA2 and GABRA4 promoters in WT hippocampal progenitors and that this was significantly impaired in NFATc4
Ϫ/Ϫ cells (mean Ϯ SEM: GABRA2; WT BDNF, 15.5 Ϯ 1.4, NFATc4
Ϫ/Ϫ BDNF 6.04 Ϯ 0.82, GABRA4; WT BDNF, 3.7 Ϯ 0.4, NFATc4 Ϫ/Ϫ BDNF 2.23 Ϯ 0.03; Fig.  2 H, I ), suggesting NFATc4 as a direct transcriptional regulator of GABRA2 and GABRA4 gene expression.
Next we investigated whether NFATc4 expression and activity regulates GABRA2 and GABRA4 mRNA and protein expression in hippocampal NPCs. To this end, we used a retrovirus overexpressing NFATc4-dsred to rescue NFATc4 levels in NFATc4 Ϫ/Ϫ NPCs. As shown in Figure 3 , A-C, the percentage of cells infected with either the control (dsred) or NFATc4-dsred-overexpressing retroviruses was close to 100%. Furthermore, immunostaining confirmed NFATc4 protein expression in infected NFATc4
Ϫ/Ϫ cells (Fig. 3D) . Quantification of GABRA2 and GABRA4 mRNA levels in WT and NFATc4
Ϫ/Ϫ NPCs transduced with a control retrovirus demonstrated that, compared with the WT NPCs, GABRA2 and GABRA4 mRNA levels decreased in the absence of NFATc4 or after blocking of NFAT activity via CsA treatment (Fig. 2J,K) . Importantly, we found that GABRA2 and GABRA4 expression was fully rescued in NFATc4
Ϫ/Ϫ cells transduced with the NFATc4-dsred retrovirus compared with WT cells infected with the control virus (fold change Ϯ SEM: GABRA2; WT CsA dsred, Ϫ2.1 Ϯ 0.2; NFATc4 Ϫ/Ϫ dsred, Ϫ5.6 Ϯ 0.47; NFATc4 Ϫ/Ϫ NFATc4-dsred, Ϫ1.2 Ϯ 0.12; GABRA4; WT CsA dsred, Ϫ1.9 Ϯ 0.1; NFATc4 Ϫ/Ϫ dsred, Ϫ4.2 Ϯ 0.51; NFATc4 Ϫ/Ϫ NFATc4-dsred, Ϫ1.05 Ϯ 0.2; Fig. 2 J, K ) . We then analyzed whether NFATc4 expression and activity correlates with increased GABRA2 and GABRA4 protein expression at the single-cell level. Indeed, immunocytochemistry proved that the number of cells expressing high levels of GABRA2 and GABRA4 was significantly lower in differentiating NFATc4
Ϫ/Ϫ compared with WT NPCs (mean Ϯ SEM: GABRA2; WT, 41.85 Ϯ 1.9%; NFATc4 Ϫ/Ϫ , 1.7 Ϯ 1.13%; p Ͻ 0.001, Student's t test; GABRA4; WT, 65.23 Ϯ 7.9%; NFATc4 Ϫ/Ϫ , 10.1 Ϯ 4.05%; Fig. 4A-D) . Consistent with these data, inhibition of calcineurin-dependent NFATc4 transcriptional activity by CsA (100 ng/ml) treatment in WT NPCs phenocopied NFATc4 Ϫ/Ϫ cells (mean Ϯ SEM: GA-BRA2; NFATc4 Ϫ/Ϫ , 1.7 Ϯ 1.13%; WT CsA 4.9 Ϯ 2.1%; p Ͻ 0.001, Student's t test; GABRA4; NFATc4 Ϫ/Ϫ , 10.1 Ϯ 4.05%; WT CsA, 6.1 Ϯ 2.3%; Fig. 4A-D) . Furthermore, by single-cell analysis of transfected cells, we found that NFATc4 overexpression in NFATc4 Ϫ/Ϫ cells rescued GABRA2 and GABRA4 protein levels (Fig. 4 E, F ) . Finally, in support of the hypothesis that NFATc4 transcriptional activity drives GABRA2 and GABRA4 expression, we observed that NFATc4 nuclear localization correlated with increased expression of GABA A R subunits (Fig. 4 E, F ) .
GABAergic excitation increases NFATc4 transcriptional activity on GABRA2 and GABRA4 promoter via calcineurin activation in early neural stem/progenitor cells Calcium signaling tightly regulates NFATc4 activation and function through calcineurin activity (Shaw et al., 1995) . Given that GABAergic depolarization increases intracellular Ca 2ϩ via acti- vation of Ca 2ϩ channels and via release of Ca 2ϩ from internal stores Young et al., 2010) , we hypothesized that GABRA A R stimulation might increase NFATc4 activity in hippocampal progenitors. To determine NFATc4 responsiveness to GABA A R stimulation, we cotransfected WT vehicle-treated or WT CSA-treated NPCs with an artificial luciferase reporter construct driven by either GABRA2 or GABRA4 promoters and a constitutively active reporter control construct driven by HSV-TK promoter. After 24 h in differentiating conditions, we stimulated NPCs with either a vehicle or the GABA A R agonist muscimol (10 m) for 6 h and found that luciferase activity increased in response to GABA A R stimulation for GABRA2 and GABRA4 promoters compared with a vehicle (mean Ϯ SEM: GABRA2; WT vehicle, 1.8 Ϯ 0.4; WT muscimol, 5.1 Ϯ 1.2; GABRA4; WT vehicle, 2.7 Ϯ 0.75; WT muscimol, 5.8 Ϯ 0.8; Fig. 5 A, B) . In addition, CsA treatment blocked the GABA A R-mediated enhancement in luciferase activity on both promoters (Fig.  5 A, B) , suggesting that GABAergic transmission regulates NFATc4 transcriptional activity via GABRA A R/calcineurin stimulation (mean Ϯ SEM: GABRA2; WT CsA vehicle, 2.6 Ϯ 0.5; WT CsA muscimol, 3.1 Ϯ 0.7; GABRA4; WT CsA vehicle, 3.0 Ϯ 0.7; WT CsA muscimol, 3.6 Ϯ 1.0). Consistent with these data, immunocytochemistry showed that, compared with the vehicle, a significantly higher number of differentiating NPCs exhibited increased NFATc4 nuclear translocation upon muscimol administration and this was fully blocked by CsA treatment (mean Ϯ SEM: WT vehicle, 14.6 Ϯ 2.3%; WT muscimol, 34.0 Ϯ 4.6%; WT CsA vehicle, 4.3 Ϯ 2.1%; WT CsA muscimol, 6.6 Ϯ 1.5%; Fig. 5C,D) . Importantly, the majority of the cells that exhibit increased GABRA2 and GABRA4 expression and NFATc4 nuclear translocation are positive for the neural stem cells markers Sox2 and Hes5 (Ferri et al., 2004; Lugert et al., 2010) and negative for Neurod1, a marker of neuroblasts (Gao et al., 2009) , suggesting that the GABA A R/NFATc4 axis is active in early stem/progenitor cells (Fig. 5 E, F ) .
Altogether, these data suggest a positive excitatory feedback loop between GABAergic signaling and NFATc4 activity in which stimulation of GABA A R increases calcineurin/NFATc4 activity that in turn regulates GABRA2 and GABRA4 expression directly in early adult hippocampal stem/progenitor cells.
GABA A R stimulation promotes adult hippocampal neurogenesis via NFATc4 activity
GABAergic excitation controls neuronal differentiation, integration, and maturation of neural progenitors (Tozuka et al., 2005; Ge et al., 2006). To investigate whether NFATc4 signaling is required for GABAergic control of hippocampal neurogenesis, we tested whether GABAergic excitation would affect neuronal differentiation via NFATc4. To this end, we infected WT and NFATc4 Ϫ/Ϫ NPCs with either the control or NFATc4-dsred retrovirus and then treated the cells with a vehicle or with muscimol (10 M), a specific GABA A R agonist, to enhance GABAergic transmission. After 1 d of differentiation, cells were fixed and double immunolabeled for nestin and for the neuronal marker MAP2 to detect the percentage of cells committed toward neuronal lineage. After 1 d in differentiating conditions, we observed 4 different populations derived from WT NPCs transduced with the control virus (Fig. 6 A, B) . Indeed, at this stage, most of the cells (ϳ70%) are still undifferentiated and positive only for nestin (mean Ϯ SEM: WT dsred vehicle-treated, 71 Ϯ 1.9%; WT dsred CsA and vehicle-treated, 68.5 Ϯ 0.2%; NFATc4
Ϫ/Ϫ dsred vehicle-treated, 68.0 Ϯ 1.4%); ϳ20% are already committed to ϩ /nestin Ϫ (ϳ4%; mean Ϯ SEM: WT dsred muscimoltreated, 4.0 Ϯ 0.3%) and MAP2 ϩ /nestin ϩ (ϳ40%; mean Ϯ SEM: WT dsred muscimol-treated, 40.3 Ϯ 1%) populations and a decrease in the number of undifferentiated cells (see Fig. 6B-F Ϫ/Ϫ -dsred, and NFATc4 Ϫ/Ϫ -NFATc4-dsred NPCs cultured for 20 h in differentiating conditions and belonging to four different populations expressing, respectively: nestin, MAP2, nestin ϩ MAP2, or none of the two markers after treatment with either vehicle or muscimol (10 m). Data are expressed as percentage of the total number of viable cells (DAPI staining). Approximately 100 cells were counted for each of three different coverslips. Data are shown as mean Ϯ SEM; n ϭ 3; one-way ANOVA followed by Bonferroni post hoc test (see Table 1 for statistics).
compared with vehicle, indicating impaired responsiveness toward GABA signaling induced via GABA A R agonist administration (see Fig. 6B-F Ϫ/Ϫ NFATc4-dsred muscimol-treated, 4.11 Ϯ 0.14%; see Fig. 6C ,D, Table 1 for statistics). Consistent with this evidence, CsA-treated WT NPCs show no response to muscimol administration, phenocopying the NFATc4 Ϫ/Ϫ cells (see Fig. 6C ,D, Table 1 for statistics). Furthermore, we observed no difference in the survival of NPCs after muscimol administration, as confirmed by quantification of the number of caspase3-positive cells and of the pyknotic nuclei in vehicle versus muscimol-treated NPCs (data not shown).
Importantly, muscimol administration promotes the nuclear localization of NFATc4 in a subpopulation of nestin ϩ neural progenitor cells and not in DCX ϩ neuroblasts, confirming that NFATc4 is nuclear and therefore likely active at early stage of adult hippocampal progenitor cells development (Fig. 7) .
To determine whether NFATc4 activity is required for GABA A Rdependent neuronal differentiation in the adult brain, we injected stereotaxically the control retrovirus expressing dsred into the DG of a group of adult WT and NFATc4 Ϫ/Ϫ mice or the NFATc4-dsred expressing retrovirus in the DG of NFATc4 Ϫ/Ϫ mice to selectively rescue NFATc4 expression in hippocampal progenitor cells. The three groups of mice were then injected daily for 24 d with either the GABA A R agonist muscimol (4 mg/kg) or the vehicle (Fig. 8A) . We then assessed the effect of GABAergic excitation on hippocampal progenitor cells differentiation by counting the percentage of retrovirus-infected cells positive for the neuronal marker CB in the three groups of mice. Indeed, the treatment with the GABA A R agonist substantially increased the percentage of neuronal differentiation (CB ϩ /dsred ϩ cells) in WT and in NFATc4 Ϫ/Ϫ mice in which NFATc4 expression was rescued by retrovirus, but not in the absence of NFATc4 (mean Ϯ SEM: WT dsred vehicle 50.8 Ϯ 1.9%; WT dsred muscimol, 78.8 Ϯ 2.7%; NFATc4 Ϫ/Ϫ NFATc4-dsred vehicle, 49.16 Ϯ 5.6%; NFATc4 Ϫ/Ϫ NFATc4-dsred muscimol, 72.9 Ϯ 3.76; Fig. 8B,C) . Consistent with these data, we found that, 24 d after BrdU injections, the total number of BrdU Fig. 8E,F) . Importantly, in NFATc4
Ϫ/Ϫ mice, we observed no effect on the commitment of NPCs after muscimol administration. Moreover, despite the confirmation of a basal difference in NPC survival between WT and NFATc4 Ϫ/Ϫ mice (as we have shown previously: Quadrato et al., 2012), we did not observe a difference in the total number of BrdU ϩ cells in muscimol-treated compared with vehicle-treated WT mice. This confirms that activation of the GABA A R/NFATc4 axis selectively affects the commitment and not the survival of NPCs (Fig. 8D,G) .
Altogether, these data further suggest NFATc4 as a novel and essential regulator of GABAergic excitation in hippocampal adult-born neurons. 
GABA A R-mediated increase in adult hippocampal neurogenesis modulates anxiety response through NFATc4
Administration of GABA A R agonists, including muscimol, decreases the anxiety level in rodents (Zarrindast et al., 2001; Lippa et al., 2005) . It has been also shown that increase in adult hippocampal neurogenesis after exposure to enriched environment or drug administration exerts anxiolytic effect in rodents (Santarelli et al., 2003; Schloesser et al., 2010) . To elucidate whether chronic GABAergic excitation is able to decrease innate anxiety in mice via NFATc4 activation, we assessed anxiety-like behavior in WT and NFATc4 Ϫ/Ϫ mice after chronic administration of muscimol. Importantly, we have reported previously that NFATc4 Ϫ/Ϫ mice show no differences in basal anxiety level or locomotor performance and that their behavioral impairment is restricted only to the formation of spatial long-term memory (Quadrato et al., 2012) . Therefore, NFATc4
Ϫ/Ϫ mice are suitable for studying the modulation of anxiety level after chronic GABA A R stimulation. As a behavioral read out of anxiety levels, we used the EPM, a classical rodent model of anxiety used for testing anxiogenic and anxiolitic compounds (Hogg, 1996) . WT and NFATc4
Ϫ/Ϫ mice were injected daily for 24 d with either muscimol (4 mg/kg) or vehicle and then 24 h after the last injection tested in the EPM (Fig. 9A) . Consistent with previous data (Quadrato et al., 2012), we found no difference in time spent in open arms between vehicle-injected WT and NFATc4 Ϫ/Ϫ mice (mean Ϯ SEM: WT vehicle, 4.12 Ϯ 1.95%; NFATc4 Ϫ/Ϫ vehicle, 18.06 Ϯ 3.97%; Fig. 9A-C) , but, as predicted, we observed a significant increase in the time that WT mice spent in open arms in response to muscimol administration (mean Ϯ SEM: WT vehicle, 4.12 Ϯ 1.95%; WT muscimol, 57.02 Ϯ 10.06%; Fig. 9A-C) . Similarly, we found that, consistent with a reduction in anxiety levels, muscimol-treated mice showed a tendency to spend more time in the crossing area and to travel more compared with vehicle-treated mice (Fig. 9 E, F ) . Importantly, this effect was not observed in NFATc4 Ϫ/Ϫ mice (mean Ϯ SEM: NFATc4 Ϫ/Ϫ vehicle, 18.06 Ϯ 3.97% NFATc4 Ϫ/Ϫ muscimol, 28.28 Ϯ 3.23%; Fig.  9A-C) , confirming that GABA A R stimulation decreases innate anxiety in mice via NFATc4 activation.
To investigate the contribution of adult hippocampal neurogenesis in the NFATc4-mediated modulation of anxiety levels, we ablated adult neurogenesis in mice after GABA A R stimulation by using the DNA-alkylating agent temozolomide (TMZ), as described previously (Garthe et al., 2009) . We subjected the mice injected with muscimol or vehicle to treatment with TMZ (25 mg/kg) for 3 d every week for 4 weeks (Fig. 9A ). After chronic administration of both muscimol and TMZ, we did not observe any weight loss or behavioral abnormality. To confirm the suppression of neurogenesis after TMZ treatment, BrdU (75 mg/kg) was injected for the first 3 d twice per day and BrdU staining was performed 4 weeks after injection. Consistent with previous data by Garthe et al. (2009) , the number of BrdU ϩ cells in the DG decreased by Ͼ80% (Fig. 9 ) in TMZ-treated mice compared with vehicle. Importantly, we found that, after depletion of the pool of newborn neurons, the anxiolytic effect of muscimol was blocked (mean Ϯ SEM: WT TMZ, 18.74 Ϯ 2.67%; WT TMZ muscimol, 30.83 Ϯ 5.6%; Fig. 9 B, C) , suggesting that NFATc4-dependent increase in neurogenesis is required for the anxiolytic effect observed in mice after GABA A R stimulation. To demonstrate that the anxiolytic effects observed are consistent with the time course required for neurogenesis, we tested the behavior of the mice in the EPM task 4 and 24 h after a single dose injection of muscimol. We observed an increase in the time spent in the open arms after 4 h but, as opposed to chronic administration, the anxyolitic effect of muscimol was not observed at the 24 h time points (Fig.  9 H, I ). These data suggest that, although the acute administration of muscimol has an effect on other brain regions, its chronic anxiolytic effect is mediated via increased neurogenesis.
Discussion
The NFAT (c1-c4) proteins belong to a family of activitydependent transcription factors that transduce and integrate neuronal-activity-driven stimuli in a number of cell types after calcium influx and calcineurin activation (Clipstone and Crabtree, 1992; Rao et al., 1997; Graef et al., 1999; Graef et al., 2003; Crabtree and Schreiber, 2009; Vashishta et al., 2009) . Specifically, we recently showed that NFATc4 regulates synaptic plasticity and long-term memory formation in the adult hippocampus by transducing BDNF signaling in hippocampal newborn neurons (Quadrato et al., 2012) . Dendritic BDNF regulates activity-dependent hippocampal synaptic plasticity (Waterhouse and Xu, 2009 ) by promoting the differentiation of hippocampal adult-born neurons via GABAergic transmission (Waterhouse et al., 2012) . These observations suggested that NFATc4 may act as a transcriptional link between changes in neuronal activity and GABAergic signaling in the adult hippocampal neurogenic niche. In support of this hypothesis, here, we have identified GABAergic signaling as a central pathway transcriptionally targeted by NFATc4.
Several studies suggest that gene expression levels of the different subunits of the GABAR change in response to extracellular stimuli (Tseng et al., 1994; Harris et al., 1995) . However, despite the fact that GABA is the most important inhibitory transmitters at CNS synapses and that alterations in GABA A R expression levels are implicated in the pathogenesis of several CNS disorders including anxiety (Möhler, 2006) , little was known about the transcriptional regulation of the GABA A R subunits.
Our data show that, in the absence of NFATc4, BDNF fails to stimulate the GABRA2 and GABRA4 promoters, leading to downregulation of GABRA2 and GABRA4 gene and protein expression in NPCs. In addition, we found that NFATc4 occupies specific transcriptional binding sites on GABRA2 and GABRA4 promoters and drives their expression, as shown by the ChIP and luciferase assays, respectively. Furthermore, NFATc4 rescue in null NPCs restores GABRA2 and GABRA4 expression levels, further confirming NFATc4 as a major player in the transcriptional machinery regulating GABRA A R expression.
NFAT-mediated transcriptional regulation is orchestrated, in many cases, by the formation of composite regulatory complexes (Macián et al., 2001; Soto-Nieves et al., 2009) . Indeed, via genome-wide analysis, we have identified a number of transcription factors dysregulated in NFATc4 Ϫ/Ϫ NPCs, including the four members of the early growth responsive (EGR) protein fam- Figure 10 . Graphical abstract summarizing the findings. ily (Table 2 ). EGR3 in particular has been shown to regulate GABRA4 expression through direct binding to its promoter after BDNF administration (Roberts et al., 2005) . Similarly, through bioinformatics analysis, we have identified single and composite potential responsive elements for NFAT and other activitydependent transcription factors, including EGRs, in the promoter region of the GABRA2 and GABRA4 genes (data not shown). These observations suggest that NFATc4 may control GABAergic signaling transcriptionally in hippocampal NPCs by regulating other activity-dependent transcription factors and by forming composite enhancer complexes on the GABRA2 and GABRA4 genomic cluster.
We also demonstrate here that calcineurin activity is required for NFATc4-dependent regulation of GABRA A R in hippocampal NPCs. Indeed, CsA-mediated inhibition of calcineurin activity blocks NFATc4 binding to the GABRA2 and GABRA4 promoters and leads to a decrease in their expression, phenocopying NFATc4 absence.
The major cellular event that leads to calcineurin activation is an increase in intracellular calcium (Rusnak and Mertz, 2000) . It is known that GABAergic depolarization enhances Ca 2ϩ levels, mainly via activation of Ca 2ϩ channels and via release of Ca 2ϩ from internal stores Young et al., 2010) . Along the same lines, in our study, we show that enhancement of GABAergic transmission in NPCs leads to increases in NFATc4 transcriptional activity via calcineurin activation. GABAergic depolarization after the administration of GABA A R agonists increases Ca 2ϩ levels in hippocampal neural progenitor cells, promoting activity-dependent neuronal differentiation (Tozuka et al., 2005; Ge et al., 2006) . These findings are consistent with the present study, in which we found that administration of a selective agonist of GABA A R increases the percentage of new neurons generated from hippocampal progenitor cells both in vitro and in vivo. The same treatment did not produce any effect in NFATc4 Ϫ/Ϫ mice, but, importantly, selective NFATc4 rescue of function in hippocampal NPCs derived from null mice restores neuronal differentiation to the WT level after muscimol administration. Interestingly, we have shown that the GABA A R/ NFATc4 axis is selectively active in a subpopulation of early neural stem/progenitor cells, suggesting a transient effect of NFATc4. Indeed, the nuclear translocation of NFATc4 induced by GABAergic excitation occurs only in a restricted time frame that is critical for neural stem/progenitor cells fate choice. These data suggest a major role for NFATc4 in promoting neuronal differentiation in adult hippocampal progenitor cells after GABAergic excitation.
In the last several years, there has been speculation about the role of adult-born hippocampal neurons in the regulation of cognitive and emotional response. Although the hypothesis that a decrease in hippocampal neurogenesis per se might result in depression or anxiety has generally been rejected (Petrik et al., 2012) , increasing evidence suggests that adult-born neurons play an important role in both discrimination of similar memory traces (pattern separation; Aimone et al., 2006; Dupret et al., 2008; Clelland et al., 2009; Deng et al., 2010; Sahay et al., 2011) and in buffering stress and depressive behavior (Snyder et al., 2011) . Specifically, the current standing of the neurogenesis hypothesis on emotional and depressive disorders infers that the treatment of anxiety/depression-related behavior in mice requires intact hippocampal neurogenesis (Santarelli et al., 2003; David et al., 2009; Surget et al., 2011) . Furthermore, increases in adult neurogenesis after physiological stimuli that drive changes in neuronal activity, including exposure to enriched environment and running, is associated with a rescue of anxiety-like phenotype (Schloesser et al., 2010; Onksen et al., 2012) .
Similarly, we found that increased chronic GABAergic excitation decreases the anxiety response in WT mice, but not in in NFATc4
Ϫ/Ϫ mice, in which the hippocampal neurogenic response is impaired. Importantly, TMZ-dependent ablation of neurogenesis phenocopied NFATc4 Ϫ/Ϫ mice, further suggesting that an increase in adult hippocampal neurogenesis is required for the anxiolytic effect of GABA A R stimulation. Although our data demonstrate the essential role of hippocampal adult-born neurons in controlling anxiety, future studies are needed to elucidate the crosstalk between adult hippocampal neurogenesis and the function of other well characterized limbic structures involved in the anxiety response.
In summary, we have identified a positive excitatory feedback loop between GABAergic signaling and NFATc4 in which stimulation of GABA A R raises calcineurin/NFATc4 transcriptional activity, leading to increased adult hippocampal neurogenesis (Fig. 10A) . These results provide novel functional and molecular insights into the regulation of anxiety, thus highlighting the therapeutic potential of the modulation of adult hippocampal neurogenesis via the GABA A R/NFATc4 axis in emotional disorders.
